Skip to content

Clinical trials

Completed Phase 2 Hemolysis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemolysis Phase: Phase 2 Status: Completed Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20111
20121
20131
20182
20191
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Apellis Pharmaceuticals, Inc.1
Emory University1
Forma Therapeutics, Inc.1
Helse Fonna1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
University Hospital, Essen1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemolysis9
Anemia5
Anemia, Hemolytic, Autoimmune3
Hematologic Diseases3
Hemoglobinuria, Paroxysmal3
Anemia, Sickle Cell2
Genetic Diseases, Inborn2
Anemia, Hemolytic1
Hemoglobinopathies1
Hemoglobinuria1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.